Stay updated on Dapagliflozin in Respiratory Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Respiratory Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Respiratory Failure Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.2 replaces the previous v3.3.1. No visible changes to study details or page functionality.SummaryDifference0.0%

- Check14 days agoChange DetectedThese changes are minor metadata updates: a PubMed publications note and a revision label (v3.3.1) that do not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedRemoved the government funding lapse notice that informed users about potential date-lag and directed them to NIH/OPM status pages. This change does not affect the trial details, eligibility criteria, or outcomes.SummaryDifference0.2%

- Check35 days agoChange DetectedThe Delhi site name shows a diacritic variation ('Sāket' vs 'Saket') with the same postal code 110017, indicating a minor typographical normalization of the location. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

- Check71 days agoChange Detected- Page version updates to v3.1.0. - Several drug-safety related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) are removed, indicating a narrowing of scope or rebranding rather than the addition of new topics.SummaryDifference0.3%

Stay in the know with updates to Dapagliflozin in Respiratory Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Respiratory Failure Clinical Trial page.